HCPCS code J9021 — Inj, aspara, rylaze, 0.1 mg. Status: Active. Effective Jan 1, 2022. Source: CMS HCPCS Level II.

J9021

Active

Inj, aspara, rylaze, 0.1 mg

Injection, asparaginase, recombinant, (rylaze), 0.1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9437

MUE — Medically Unlikely Edits

Maximum units of J9021 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 1500
Outpatient Hospital 1500
Practitioner Services 1500

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
68727-0900-03 Rylaze

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q1
    Inj, aspara, rylaze, 0.1 mg